GlobeNewswire by notified

Namogoo Announces New Integration With Google Cloud to Shed New Light on the Customer Journey

Share

HERZLIYA, Israel, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Namogoo, the world's first Digital Journey Continuity platform, has integrated with Google Cloud to add new layers to the customer journey that digital executives, marketing and data teams are currently lacking.

Namogoo provides a new generation of data points and segments that are unique in the industry and do not rely on cookies and visitor history. Namogoo will now offer its SaaS platform on Google Cloud's trusted infrastructure and will integrate with Google Cloud services, including BigQuery, Looker, Dataflow and Pub/Sub, enabling website owners and digital teams to more easily integrate data, analyze it in BigQuery, and generate real-time insights and predictions. This builds upon Namogoo's existing integrations with Google Analytics and Google Ads.

Namogoo's technology brings together commonly used data on mobile devices, consumer habits, commerce behavior, and the environment to help businesses understand the impact such variables have on the overall customer journey. From predicted lifetime value to probability of abandonment, and through connection speed and device efficiency, Namogoo's unique, commerce-oriented data points and segments help paint a clearer picture of the customer. Combining these insights with Contentsquare's holistic view of the digital customer experience allows teams to unlock a greater understanding of their digital visitors, fueling smarter optimization and more impactful personalization.

With customer experience as the key competitive differentiator for businesses today, understanding how high-value customers behave and what they expect from the online experience is critical to boosting customer happiness, building greater digital trust, and driving digital revenue growth.

Namogoo's integration with Google Cloud helps businesses allocate advertising budgets more effectively and significantly increase their return on ad spend by identifying gold populations that convert higher - in real time. It also identifies populations that do not convert and areas that need to be fixed.

Namogoo sees a natural fit in Google Cloud, due to the ability of Google Cloud's products and infrastructure to handle the large volumes of data and the ability to take action in real-time.

Namogoo's technology runs on 1.5 Billion unique monthly visitors of leading companies including M&S, Argos, Asics, Carhartt, 1-800-contacts, Eddie Bauer, Dollar Shave Club and many others, and is applicable to various industries such as retail, commerce, CPG, travel, marketplaces and fintech.

About Namogoo

Namogoo is the world's first Digital Journey Continuity platform, helping over 1,000 unstoppable brands shape their customer journeys to fit each and every shopper's needs. Namogoo's platform autonomously adapts to each customer visit in real-time, lifting conversion rates and revenue while maintaining e-commerce retailers' margins and bolstering brand equity. Namogoo is available on all major e-commerce platforms, including Shopify, BigCommerce, Salesforce Commerce Cloud and Magneto - serving over a thousand global brands of all sizes.

Contact Information:
Ohad Greenshpan
Co-founder & CTO of Namogoo
ohad@namogoo.com

Related Images



To view this piece of content from cdn.newswire.com, please give your consent at the top of this page.


Image 1: Namogoo and Google Integration



This content was issued through the press release distribution service at Newswire.com.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)19.4.2024 12:10:00 CEST | Press release

Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira®The agreement broadens patient access and further commitment to availability of vital biologics in the U.S. and globally Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryvk in the U.S. market, the newly U.S. Food and Drug Administration (FDA) approved high-concentration interchangeable biosimilar to Humira. “This new partnership agreement supports our financial guidance and reflects Alvotech’s strong commitment to increasing patient access to more affordable healthcare,” said Robert Wessman, Chairman and CEO of Alvotech. The current multi-product commercialization partnership between T

Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award19.4.2024 12:00:00 CEST | Press release

WASHINGTON, April 19, 2024 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in the National Academy of Sciences building in Washington D.C. Klugman and Madhi received the Sabin Gold Medal, one of the highest recognitions for vaccinologists globally, for their seminal combined contributions to the development of vaccines against pneumonia and diarrheal disease – major causes of death in children in low- and middle-income countries (LMICs). Klugman first met his then-graduate student Madhi at South Africa’s University of the Witwatersrand (also known as Wits University), where Klugman established, and Madhi expanded, a now globally renowned infectious diseases research institute. Apart from pneumonia, their work focused on maternal and children’s vaccines including influenza,

Forløb af ordinær generalforsamling 202419.4.2024 11:59:58 CEST | pressemeddelelse

Investeringsforeningen Investin har i dag afholdt ordinær generalforsamling i henhold til tidligere offentliggjort dagsorden. Ledelsens beretning og årsrapporten for 2023, herunder de i januar 2024 udbetalte udlodninger samt bestyrelsens honorar for 2023 blev godkendt af generalforsamlingen. Alle de af bestyrelsen stillede forslag blev vedtaget, herunder overflytning af afdeling I&T Nordiske Aktier Large Cap og afdeling I&T Globale Aktier ESG Select samt vedtægtsændringer. Til bestyrelsen genvalgtes Kim Høibye, Jesper Lau Hansen, Henrik Vincents Johansen samt Tine Roed, og bestyrelsen konstituerede sig efterfølgende med Kim Høibye som formand. Som revisor for foreningen genvalgtes EY Godkendt Revisionspartnerselskab. Eventuelle henvendelser vedrørende denne meddelelse kan rettes til direktør Tage Fabrin-Brasted på tlf. 44 55 91 60. Med venlig hilsen Investeringsforeningen Investin Tage Fabrin-Brasted Direktør

Investeringsforeningen ValueInvest Danmark – Prospektopdatering19.4.2024 11:32:00 CEST | pressemeddelelse

Opdateret prospekt for Investeringsforeningen ValueInvest Danmark offentliggøres dags dato. Der er fore­taget følgende opdateringer i prospektet: Indsættelse af regnskabstal for 2023 Prospektet er vedhæftet denne fondsbørsmeddelelse og kan endvidere downloades på www.valueinvest.dk eller rekvireres ved henvendelse til BI Management A/S, Bredgade 40, 1260 København K, tlf. 77 30 90 00. Med venlig hilsen BI Management A/S Martin Fjordlund Smidt Direktør Vedhæftet fil Prospekt IF ValueInvest Danmark 2024.04.19 FINAL clean inkl. bilag

Forløb af ordinær generalforsamling i Investeringsforeningen ValueInvest Danmark den 19. april 202419.4.2024 11:30:00 CEST | pressemeddelelse

Bestyrelsens beretning Bestyrelsens beretning blev taget til efterretning. Årsrapport, udbytte og bestyrelsesmedlemmernes honorar Årsrapporten for 2023 blev enstemmigt godkendt, herunder bestyrelsens honorar samt forslag om udbetaling af udbytte på 13,60 kr. pr. bevis for andelsklasse A i ValueInvest Global KL, og udbytte på 14,60 kr. pr. bevis for andelsklasse W i ValueInvest Global KL. Udbyttebetalingen til investorerne er foretaget aconto den 5. februar 2024. Forslag fremsat af bestyrelsen Der blev ikke fremsat forslag under dette punkt. Valg til bestyrelsen Bestyrelsen havde indstillet til genvalg af Ole Steffensen, Jens Harck og Bent Erik Carlsen, der enstemmigt blev valgt som medlemmer af bestyrelsen. Valg af revisor EY Godkendt Revisionspartnerselskab blev genvalgt som revisor. Med venlig hilsen Bestyrelsen for Investeringsforeningen ValueInvest Danmark c/o BI Management A/S Bredgade 40 1260 København K

HiddenA line styled icon from Orion Icon Library.Eye